14-day Premium Trial Subscription Try For FreeTry Free
$13.48
+0.210 (+1.58%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.40 $15.18 Wednesday, 24th Apr 2024 ASMB stock ended at $13.48. This is 1.58% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.30% from a day low at $13.05 to a day high of $13.48.
90 days $0.82 $15.18
52 weeks $0.641 $15.18

Historical Assembly Biosciences prices

Date Open High Low Close Volume
Jan 05, 2024 $0.82 $0.83 $0.791 $0.81 93 808
Jan 04, 2024 $0.83 $0.83 $0.790 $0.81 154 078
Jan 03, 2024 $0.83 $0.83 $0.794 $0.81 212 049
Jan 02, 2024 $0.83 $0.86 $0.81 $0.83 300 226
Dec 29, 2023 $0.81 $0.84 $0.795 $0.82 361 601
Dec 28, 2023 $0.82 $0.84 $0.795 $0.81 425 547
Dec 27, 2023 $0.83 $0.84 $0.80 $0.81 202 477
Dec 26, 2023 $0.790 $0.84 $0.790 $0.82 677 155
Dec 22, 2023 $0.766 $0.80 $0.766 $0.790 217 889
Dec 21, 2023 $0.780 $0.790 $0.759 $0.759 238 555
Dec 20, 2023 $0.759 $0.779 $0.750 $0.770 254 991
Dec 19, 2023 $0.753 $0.778 $0.735 $0.760 190 411
Dec 18, 2023 $0.770 $0.790 $0.753 $0.762 175 711
Dec 15, 2023 $0.80 $0.81 $0.753 $0.753 527 394
Dec 14, 2023 $0.770 $0.790 $0.750 $0.790 252 211
Dec 13, 2023 $0.732 $0.781 $0.720 $0.781 270 066
Dec 12, 2023 $0.730 $0.745 $0.703 $0.732 359 646
Dec 11, 2023 $0.740 $0.763 $0.731 $0.759 199 557
Dec 08, 2023 $0.741 $0.770 $0.722 $0.760 205 452
Dec 07, 2023 $0.748 $0.770 $0.725 $0.743 149 049
Dec 06, 2023 $0.730 $0.790 $0.726 $0.770 197 860
Dec 05, 2023 $0.725 $0.760 $0.720 $0.753 360 696
Dec 04, 2023 $0.721 $0.750 $0.720 $0.740 205 982
Dec 01, 2023 $0.700 $0.730 $0.700 $0.716 91 901
Nov 30, 2023 $0.720 $0.741 $0.700 $0.700 373 345
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT